ID17723A - Senyawa untuk pengobatan - Google Patents

Senyawa untuk pengobatan

Info

Publication number
ID17723A
ID17723A IDP971328A ID971328A ID17723A ID 17723 A ID17723 A ID 17723A ID P971328 A IDP971328 A ID P971328A ID 971328 A ID971328 A ID 971328A ID 17723 A ID17723 A ID 17723A
Authority
ID
Indonesia
Prior art keywords
compound
treatment
Prior art date
Application number
IDP971328A
Other languages
English (en)
Inventor
Dirk Casimir Maria Leysen
Gerardus Stephanus Frans Ruigt
Joannes Theodorus Mari Linders
Fredericus Antionius Dijcks
Simon James Anthony Grove
Duncan Robertson Rae
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ID17723A publication Critical patent/ID17723A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IDP971328A 1996-04-19 1997-04-21 Senyawa untuk pengobatan ID17723A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201065 1996-04-19

Publications (1)

Publication Number Publication Date
ID17723A true ID17723A (id) 1998-01-22

Family

ID=8223896

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971328A ID17723A (id) 1996-04-19 1997-04-21 Senyawa untuk pengobatan

Country Status (25)

Country Link
EP (1) EP0898566B1 (id)
JP (1) JP4008033B2 (id)
CN (1) CN1139580C (id)
AR (1) AR006719A1 (id)
AT (1) ATE227278T1 (id)
AU (1) AU725847B2 (id)
BR (1) BR9708790A (id)
CA (1) CA2251820C (id)
CZ (1) CZ295747B6 (id)
DE (1) DE69716896T2 (id)
DK (1) DK0898566T3 (id)
ES (1) ES2186888T3 (id)
HK (1) HK1018271A1 (id)
HU (1) HU224637B1 (id)
ID (1) ID17723A (id)
IL (1) IL120669A (id)
NO (1) NO311976B1 (id)
NZ (1) NZ332334A (id)
PL (1) PL192561B1 (id)
PT (1) PT898566E (id)
RU (1) RU2179553C2 (id)
TR (1) TR199802104T2 (id)
TW (1) TW498070B (id)
WO (1) WO1997040027A1 (id)
ZA (1) ZA973209B (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080773A (en) 1997-10-14 2000-06-27 Akzo Nobel, N.V. Benzylamine derivatives which are useful in treating psychiatric disorders
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
EE200200134A (et) * 1999-09-14 2003-04-15 Aventis Pharmaceuticals Inc. D4 retseptori antagonistidena toimivad bensisoksasolüül-, püridoisoksasolüül- ja benstienüülfenoksüderivaadid
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
GB0321538D0 (en) 2003-09-13 2003-10-15 Glaxo Group Ltd Therapeutically useful compounds
EP1925305A1 (en) * 2006-10-23 2008-05-28 N.V. Organon Ih channel inhibitors for the promotion of wakefulness
MX2011006680A (es) 2008-12-24 2011-07-12 Astrazeneca Ab Compuestos etanaminicos y su uso para tratar la depresion.
EP2473489B1 (en) 2009-07-07 2013-08-21 Merck Sharp & Dohme B.V. 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives
CN102942464B (zh) * 2012-12-06 2015-04-08 西北师范大学 化合物1-(2-卤苯基)-3-甲基-丁酮-1的合成方法
CN112300061B (zh) * 2020-10-06 2022-02-18 大连理工大学 一种含氮杂环二芳酮化合物的制备方法
GB202103017D0 (en) 2021-03-03 2021-04-14 King S College London Compounds
GB202103012D0 (en) 2021-03-03 2021-04-14 King S College London Compounds
GB202103008D0 (en) 2021-03-03 2021-04-14 King S College London Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980365A (en) * 1987-07-13 1990-12-25 Hoechst-Roussel Pharmaceuticals Inc. N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DE69716896T2 (de) 2003-07-24
EP0898566B1 (en) 2002-11-06
JP2000508672A (ja) 2000-07-11
ES2186888T3 (es) 2003-05-16
BR9708790A (pt) 1999-08-03
AU2387097A (en) 1997-11-12
NZ332334A (en) 2000-06-23
JP4008033B2 (ja) 2007-11-14
PL192561B1 (pl) 2006-11-30
IL120669A (en) 2001-04-30
NO984836L (no) 1998-12-16
EP0898566A1 (en) 1999-03-03
RU2179553C2 (ru) 2002-02-20
IL120669A0 (en) 1997-08-14
DE69716896D1 (de) 2002-12-12
AR006719A1 (es) 1999-09-08
HUP9901434A2 (hu) 1999-08-30
CN1219169A (zh) 1999-06-09
CA2251820A1 (en) 1997-10-30
TR199802104T2 (xx) 2000-09-21
HK1018271A1 (en) 1999-12-17
PL329348A1 (en) 1999-03-29
DK0898566T3 (da) 2003-03-03
HU224637B1 (hu) 2005-12-28
CN1139580C (zh) 2004-02-25
HUP9901434A3 (en) 2001-11-28
ZA973209B (en) 1997-11-20
PT898566E (pt) 2003-03-31
AU725847B2 (en) 2000-10-19
TW498070B (en) 2002-08-11
NO311976B1 (no) 2002-02-25
CA2251820C (en) 2007-03-27
NO984836D0 (no) 1998-10-16
CZ334998A3 (cs) 1999-06-16
WO1997040027A1 (en) 1997-10-30
CZ295747B6 (cs) 2005-10-12
ATE227278T1 (de) 2002-11-15

Similar Documents

Publication Publication Date Title
ID19609A (id) Senyawa-senyawa heterosiklik
ID19403A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID19430A (id) Senyawa senyawa heterosiklik
BR9709230A (pt) Composto
ID15904A (id) Senyawa-senyawa tiofenopirimidina
DK0777671T3 (da) Spiro-azabicykliske forbindelser
NO983266D0 (no) Distribuert Behandling
ID19476A (id) Senyawa piridilpirol
BR9707051A (pt) Composto
DE69716924T2 (de) Phosphonat-nukleotid-verbindungen
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
ID18685A (id) Senyawa trisiklik tersubstitusi
PT906288E (pt) Novos compostos
BR9705635A (pt) Compostos
ID17723A (id) Senyawa untuk pengobatan
IS4789A (is) Meðferðarefnasambönd
NO983263L (no) Distribuert behandling
BR9711205A (pt) Composto
DK0923594T3 (da) Bromotiacumicinforbindelser
FI970151A0 (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
IS4932A (is) Ný efnasambönd
KR970053540U (ko) 침시술용 침관
ID17103A (id) Senyawa-senyawa sulfonamida